ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
Dow Jones
42.732,13
0,80%
Euro vs US Dollar
1,03115
0,00%
Bitcoin
98.320,39
0,11%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Abbott Laboratories (ABT)

  7. Abbott Laboratories (ABT) News

ABT

Abbott Laboratories (ABT)

Abbott Laboratories
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:ABT
DatumZeitQuelleÜberschriftSymbolFirma
03/01/202523h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/01/202523h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/01/202523h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
02/01/202515h00PR Newswire (US)Abbott Hosts Conference Call for Fourth-Quarter EarningsNYSE:ABTAbbott Laboratories
17/12/202422h03PR Newswire (Canada)Le système FreeStyle Libre 2® d'Abbott est maintenant remboursé pour les enfants et les adultes de l'Alberta vivant avec le diabèteNYSE:ABTAbbott Laboratories
17/12/202422h03PR Newswire (Canada)Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in AlbertaNYSE:ABTAbbott Laboratories
17/12/202413h00PR Newswire (US)Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the HeartNYSE:ABTAbbott Laboratories
13/12/202416h58PR Newswire (US)Abbott Increases Quarterly Dividend for 53rd Consecutive YearNYSE:ABTAbbott Laboratories
08/12/202403h14PR Newswire (US)University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from AbbottNYSE:ABTAbbott Laboratories
25/11/202413h00PR Newswire (US)Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic StenosisNYSE:ABTAbbott Laboratories
18/11/202412h00PR Newswire (US)Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, IrelandNYSE:ABTAbbott Laboratories
15/11/202422h13Edgar (US Regulatory)Form 8-K - Current reportNYSE:ABTAbbott Laboratories
04/11/202422h02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
01/11/202411h57IH Market NewsIndex Futures Rise on Jobs Report and Chevron, Exxon Earnings Anticipation; Oil Prices SurgeNYSE:ABTAbbott Laboratories
01/11/202411h55IH Market NewsAmazon Up 6%, Atlassian Jumps 20%; Intel Posts Surprising Profit; Abbott Wins Infant Formula LawsuitNYSE:ABTAbbott Laboratories
31/10/202422h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ABTAbbott Laboratories
30/10/202415h08PR Newswire (Canada)Un nouveau rapport canadien montre qu'une attitude positive est préférable à la critique dans la prise en charge du diabèteNYSE:ABTAbbott Laboratories
30/10/202414h50PR Newswire (Canada)New Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes ManagementNYSE:ABTAbbott Laboratories
24/10/202415h00PR Newswire (US)Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart FailureNYSE:ABTAbbott Laboratories
23/10/202423h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
21/10/202422h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
16/10/202413h37Edgar (US Regulatory)Form 8-K - Current reportNYSE:ABTAbbott Laboratories
16/10/202413h30PR Newswire (US)Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance RangeNYSE:ABTAbbott Laboratories
10/10/202415h00PR Newswire (US)Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac MappingNYSE:ABTAbbott Laboratories
01/10/202423h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
01/10/202423h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
01/10/202423h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
01/10/202423h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
26/09/202420h00PR Newswire (US)Abbott and the Big Ten Conference Tackle U.S. Blood Shortages with First-of-its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'NYSE:ABTAbbott Laboratories
25/09/202415h00PR Newswire (US)Abbott Hosts Conference Call for Third-Quarter EarningsNYSE:ABTAbbott Laboratories
 Showing the most relevant articles for your search:NYSE:ABT

Kürzlich von Ihnen besucht

ASX
AIQ
Alternative Investment
TG
S3IA
Suedzucker Intl05 Und Flr
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten